SCHEMBL4450135

SCHEMBL4450135

C1=CC=CC=Cc2ccccc2ON=NC=CC=C1

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4450130 1.00 KDM4E (0.30) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL4450134 1.00 KDM4E (0.30) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL449597 0.84 KDM4E (0.33) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL17164340 0.82
SCHEMBL17164341 0.82
SCHEMBL17164339 0.82
SCHEMBL15961195 0.71
SCHEMBL15961193 0.71
SCHEMBL209689 0.71 TRPA1 (0.34)
SCHEMBL444958 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492377-B2 MTKI quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 2013-07-23 US claimed
CN-101528235-A Vegfr3 inhibitors JANSSEN PHARMACEUTICA NV (BE) 2009-09-09 CN disclosed
EP-2089710-A2 A METHOD FOR PHARMACOLOGICALLY PROFILING COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2009-08-19 EP disclosed
WO-2008049930-A2 A METHOD FOR PROFILING KINASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2008-05-02 WO disclosed